PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
PDL Biopharma, Inc. (PDL or 'the company') manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to public and private healthcare companies. PDL provides companies, academic institutions, and inventors with an immediate financial monetization of royalty streams for acquiring new income-generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. The company is headquartered in Reno, Nevada, the US.Scope
- Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments
- Intelligence on PDL Biopharma, Inc.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on PDL Biopharma, Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- PDL Biopharma, Inc.: Company Overview
- PDL Biopharma, Inc.: Overview and Key Facts
- PDL Biopharma, Inc.: Overview
- PDL Biopharma, Inc.: Key Facts
- PDL Biopharma, Inc.: Key Employees
- PDL Biopharma, Inc.: Key Employee Biographies
- PDL Biopharma, Inc.: Major Products and Services
- PDL Biopharma, Inc.: Key Competitors
- PDL Biopharma, Inc.: Company Analysis
- PDL Biopharma, Inc.: Business Description
- PDL Biopharma, Inc.: SWOT Analysis
- PDL Biopharma, Inc.: SWOT Overview
- PDL Biopharma, Inc.: Strengths
- PDL Biopharma, Inc.: Weaknesses
- PDL Biopharma, Inc.: Opportunities
- PDL Biopharma, Inc.: Threats
- PDL Biopharma, Inc.: Corporate Financial Deals Activity
- PDL Biopharma, Inc.: Financial Deals Overview
- PDL Biopharma, Inc.: Targets and Partners
- PDL Biopharma, Inc.: Top Deals 2019 - 2023YTD*
- PDL Biopharma, Inc.: Advisors
- PDL Biopharma, Inc.: Top Financial Advisors
- PDL Biopharma, Inc.: Corporate Venturing
- PDL Biopharma, Inc.: Divestments
- PDL Biopharma, Inc.: Recent Developments
- PDL Biopharma, Inc.: News and Events Summary
- PDL Biopharma, Inc.: Contracts
- PDL Biopharma, Inc.: Corporate Governance
- PDL Biopharma, Inc.: Financial Performance
- PDL Biopharma, Inc.: Red Flags/Distress Signals
- PDL Biopharma, Inc.: Regulatory and Legal Events
- PDL Biopharma, Inc.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
Table 1: PDL Biopharma, Inc.: Key Facts
Table 2: PDL Biopharma, Inc.: Key Employees
Table 3: PDL Biopharma, Inc.: Key Competitors
Table 4: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 5: PDL Biopharma, Inc.: Targets and Partners
Table 6: PDL Biopharma, Inc.: Top Deals 2019 - 2023YTD*
Table 7: PDL Biopharma, Inc.: Financial Advisor Ranking by Value (US$m)
Table 8: PDL Biopharma, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 9: PDL Biopharma, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 10: PDL Biopharma, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 11: PDL Biopharma, Inc.: Divestments by Geography (2019 - YTD*2023)
Table 12: PDL Biopharma, Inc.: News and Events Summary
Table 13: PDL Biopharma, Inc.: Contracts
Table 14: PDL Biopharma, Inc.: Corporate Governance
Table 15: PDL Biopharma, Inc.: Financial Performance
Table 16: PDL Biopharma, Inc.: Red Flags/Distress Signals
Table 17: PDL Biopharma, Inc.: Regulatory and Legal Events
Table 18: PDL Biopharma, Inc.: Strategy and Operations
List of Figures
Figure 1: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 2: PDL Biopharma, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 3: PDL Biopharma, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 4: PDL Biopharma, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 5: PDL Biopharma, Inc.: Divestments by Geography (2019 - YTD*2023)
